Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Bitcoin News Update: Bitcoin ETFs See $2.96 Billion Outflow as November Optimism Wanes

Bitcoin News Update: Bitcoin ETFs See $2.96 Billion Outflow as November Optimism Wanes

Bitget-RWA2025/11/23 01:22
By:Bitget-RWA

- BlackRock's Bitcoin ETFs lost $523M in single-day outflows on Nov 17, marking fifth consecutive net redemptions totaling $2.96B for November. - Despite November's historical 41.22% Bitcoin price surge, ETF redemptions signal cooling institutional/retail demand with average investor cost basis at $89,600. - Michael Saylor's firm bought 8,178 BTC at $102k average price, while JPMorgan warned Bitcoin-heavy companies risk index delistings by 2026. - BlackRock's IBIT holds 3.1% of Bitcoin supply but NAV multi

BlackRock's

exchange-traded funds (ETFs) are experiencing significant capital withdrawals, with the (IBIT) on November 17. This event marked the fifth straight day of net withdrawals from U.S. spot Bitcoin ETFs, pushing November's total outflows to $2.96 billion—making it the second-worst month for these products since their debut in January 2024. alone was responsible for $2.1 billion of these outflows, nearly matching the $3.56 billion seen in February 2025, a period that was historically strong for Bitcoin.

Despite November's reputation as a bullish month for Bitcoin, selling pressure has remained,

during this time. Geoff Kendrick, Standard Chartered's global head of digital assets research, pointed out that ETF inflows had been a major force behind Bitcoin's momentum in 2025, but recent outflows indicate waning interest from both institutional and retail investors. As a result, many investors are now at a loss, with , which is below Bitcoin's present price of about $90,000.

This wave of redemptions has led to doubts about the long-term viability of institutional participation in Bitcoin. BlackRock's

, which controls nearly 3.1% of all Bitcoin in circulation, , acquired at an average blended price of $74,433. Nevertheless, the fund's performance has been unstable, with its net asset value (NAV) multiple falling to 1.11x from a peak of 1.52x in October.

Bitcoin News Update: Bitcoin ETFs See $2.96 Billion Outflow as November Optimism Wanes image 0

Despite the ongoing volatility, some industry leaders remain optimistic.

to Bitcoin's future value, emphasizing that each serves a unique function: stablecoins as programmable money for transactions, and Bitcoin as a scarce digital asset. Saylor's company continued its aggressive accumulation, purchasing 8,178 at an average price of $102,171 this week, bringing its total Bitcoin holdings to 649,870 BTC, now worth $48.37 billion.

The recent market instability has also drawn the attention of regulators.

that firms with large Bitcoin holdings, such as MicroStrategy, could face removal from major indexes like the MSCI USA and Nasdaq 100 by January 2026. Meanwhile, BlackRock's broader business activities, including a recent dividend payout of $5.21 per share, indicate the company is balancing its crypto exposure with conventional financial strategies.

As the year draws to a close, the developments surrounding Bitcoin ETFs highlight the fragile nature of institutional trust in this asset class. While historical trends point to a possible recovery, the current wave of outflows underscores the ongoing difficulties in sustaining momentum amid persistent volatility and regulatory challenges.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

- SEC approves multiple XRP/DOGE ETFs from 21Shares, Franklin Templeton, and Grayscale, signaling growing institutional acceptance of altcoins. - 21Shares' TOXR ETF gains automatic approval via CME CF XRP-Dollar tracking, with Coinbase and BNY Mellon handling custody/admin functions. - Franklin Templeton's XRP Trust removes restrictive clauses to accelerate listing, offering regulated exposure without custody risks from ledger forks. - Grayscale expands crypto offerings with XRP/DOGE ETFs on NYSE, joining

Bitget-RWA2025/11/23 20:48
XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

- Germany's SolarPlus Forum 2025 emphasized legislative clarity, funding innovation, and cross-sector collaboration to accelerate solar adoption amid evolving energy policies. - Outdated regulations and permitting hurdles were highlighted as barriers, with calls to align Bundestag reforms with market demands like gas surcharge removal by 2026. - Cement industry growth (5.7% CAGR) and green innovations support infrastructure needs, though energy cost volatility and compliance challenges persist. - Internati

Bitget-RWA2025/11/23 20:48
Germany's Solar Turning Point: Spotlight on Legislation, Infrastructure, and Ideological Differences

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats